Seta Shahin
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- John L. Marshall (1 shared paper)Robert G Deeter (1 shared paper)Rafael G. Amado (1 shared paper)Allen Lee Cohn (1 shared paper)David R. Spigel (1 shared paper)David McCollum (1 shared paper)J. Randolph Hecht (1 shared paper)Tarek Chidiac (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Breast Cancer Research and Treatment (1 paper)Therapeutic Innovation & Regulatory Science (1 paper)Clinical Cancer Research (1 paper)Journal of Oncology Practice (1 paper)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Seta Shahin
13 papers receiving 920 citations
Seta Shahin's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 730
- Hepatology 130
- Cancer Research 111
- Pulmonary and Respiratory Medicine 209
- Pathology and Forensic Medicine 105
Countries citing papers authored by Seta Shahin
This map shows the geographic impact of Seta Shahin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seta Shahin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seta Shahin more than expected).
Fields of papers citing papers by Seta Shahin
This network shows the impact of papers produced by Seta Shahin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seta Shahin. The network helps show where Seta Shahin may publish in the future.
Co-authors
The 25 scholars most cited alongside Seta Shahin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 645 |
| 2 | 2007 | 98 | |
| 3 | 2010 | 77 | |
| 4 | 2002 | 61 | |
| 5 | 2006 | 16 | |
| 6 | 2019 | 14 | |
| 7 | Randomized double-blind phase 2 study evaluating sameday vs next-day administration of pegfilgrastim with docetaxel, doxorubicin, and cyclophosphamide (tac) in women with early stage and advanced breast cancer | 2004 | 12 |
| 8 | 2015 | 12 | |
| 9 | 2006 | 7 | |
| 10 | 2005 | 5 | |
| 11 | 2020 | 2 | |
| 12 | 2005 | 2 | |
| 13 | 2019 | 1 |
About Seta Shahin
Seta Shahin is a scholar working on Oncology, Genetics, Toxicology, Genetics and Economics and Econometrics, having authored 13 papers that have together received 952 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (7 papers), Chronic Lymphocytic Leukemia Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Statistical Methods in Clinical Trials (2 papers), Cancer Treatment and Pharmacology (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Blood disorders and treatments (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (730 citations), Hepatology (130 citations), Cancer Research (111 citations), Pulmonary and Respiratory Medicine (209 citations) and Pathology and Forensic Medicine (105 citations). Seta Shahin has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include John L. Marshall, Robert G Deeter, Rafael G. Amado, Allen Lee Cohn, David R. Spigel, David McCollum, J. Randolph Hecht, Tarek Chidiac, Edith P. Mitchell and Christopher Hagenstad. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Therapeutic Innovation & Regulatory Science, Clinical Cancer Research and Journal of Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.